Arbeitsgemeinschaft
für angewandte
Humanpharmakologie e.V

Association for
Applied Human
Pharmacology

  

> Annual Meeting > Annual Meetings - Overview > Annual Meeting 2003 > Presentations 2003 

Presentations of the Annual Meeting 2003

Session I: Today's Setting of Drug Development

R. Shah, London

Risk-benefit Evaluation in Approval of traditional and innovative Drugs (Abstract)

M. Holz-Slomczyk, BfArM, Bonn

Guidelines for Drug Approval – Today and Tomorrow (Abstract)


Session II: Socioeconomic acpects of new Drugs

M. Schlander, Witten-Herdecke

pdf
What does the society want?What-does-the-society-want-Schlander.pdf (1 MB)

J. Göben, BfArM, Bonn

What can the Society afford? (Abstract)


Session III: Essential Tools - Today and Tomorrow

B. Meibohm, Memphis

Exposure/Response vs. Dose/Response Relationship in Drug Development (Abstract)

E. Wingender, Göttingen

Using Bioinformatics for bridging the Genotype-Phenotype Gap (Abstract)


Session IV: Development of Anticancer Drugs

B. Osterwalder, Basel

Xeloda, an old cytotoxic in a new Form: new Development Paradigm required? (Abstract)

D. Voliotis, Wuppertal

Safety, Toxicity and Efficacy of Antineoplastic Compounds – a clinical View (Abstract)

D. Laurent, Berlin

Design and Evaluation of clinical Studies with Angiogenesis Inhibitors (Abstract)


Session V: Development of Anti-inflammatory Drugs

K. Brune, Erlangen-Nürnberg

Methods to assess the Safety and Efficacy of traditional Compounds (NSAID, Steroids) [Abstract]

M. F. Neurath, Mainz

Inflammatory Bowel Disease: Cytokines and Cytokine Therapies (Abstract)


Session VI: Development of Anti-Neurodegenerative Drugs

C. Gilles, Rouffach, France

Functional MRI in neurodegenerative Disease (Abstract)

A. Lammertsma, Amsterdam

Potential use of PET in Drug Development: labelled Drugs, functional Changes (e.g. Flow and Metabolism), Receptor Occupancy, Dose Response Curves (Abstract)


Session VII: Development of genetically engineered Drugs

U. Keilholz, Berlin

Gene- and Immunotherapy in Oncology: Study Concepts, Endpoints and first Results (Abstract)

V. Kessler, Freiburg

Tissue Engineering (Abstract)

F. Jakob, Würzburg

Stem Cell Therapy (Abstract)


Workshops

R. Hermann, Frankfurt, W. Haverkamp, Berlin, U. Bischoff, Hamburg

QTc - "Time series data" (Abstract)

K. Breithaupt-Grögler, Frankfurt and B. Hughes-Formella, Hamburg

Medical Writing – Report Writing (Abstract)

T. Sudhop, Bonn

pdf
Declaration of HelsinkiDecl-Helsinki-Sudhop.pdf (141 kB)

K. Olejniczak, BfArM, Bonn

Preclinical requirements to studies in children (Abstract)


Abstracts of the Annual Meeting 2003

Annual Meeting of the Association for Applied Human Pharmacology, Volume 2

Page updated: 14-05-2009